KemPharm Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,968.60
10,255.00
51,320.00
68,865.00
43,329.00
21,669
Total Accounts Receivable
20.40
22.40
2,375.00
5,061.00
2,081.00
140
Other Current Assets
50.50
0.20
383.00
431.00
1,586.00
1,912
Total Current Assets
2,039.60
10,277.60
54,078.00
74,357.00
46,996.00
23,721
Net Property, Plant & Equipment
380.20
352.20
403.00
1,970.00
2,004.00
1,753
Total Investments and Advances
-
-
-
8,200.00
3,250.00
710
Other Assets
9.20
3,084.00
109.00
360.00
206.00
562
Total Assets
2,429.00
13,713.80
54,590.00
84,887.00
52,456.00
26,746
ST Debt & Current Portion LT Debt
3,877.30
31.50
3,436.00
157.00
3,522.00
Accounts Payable
-
-
-
469.00
2,177.00
Other Current Liabilities
1,365.60
3,903.10
4,906.00
6,016.00
5,810.00
Total Current Liabilities
5,242.90
3,934.60
8,342.00
6,642.00
11,509.00
Long-Term Debt
92.80
18,115.00
18,530.00
91,827.00
89,960.00
Other Liabilities
2,813.30
15,965.90
37,839.00
5,114.00
8,503.00
Total Liabilities
8,148.90
38,015.50
64,711.00
103,583.00
109,972.00
Common Equity (Total)
24,267.30
48,508.30
10,121.00
18,696.00
57,516.00
Total Shareholders' Equity
24,267.30
48,508.30
10,121.00
18,696.00
57,516.00
Total Equity
24,267.30
48,508.30
10,121.00
18,696.00
57,516.00
Liabilities & Shareholders' Equity
2,429.00
13,713.80
54,590.00
84,887.00
52,456.00
Non-Equity Reserves
18,547.40
24,206.60
-
-
-
About KemPharm
View Profile
